Researchers at The George Institute for Global Health are studying how to lower the environmental impact of cardiovascular, kidney, and metabolic syndrome trials. The project focuses on reducing the carbon footprint of large scale medical research. Proposed strategies include using centralized trial monitoring and platform trial designs to evaluate multiple therapies simultaneously. This approach aims to maintain high standards of medical care while minimizing the resource intensity and emissions associated with traditional clinical trial structures.
